analyzing challenges in treating patients with relapsed/refractory follicular lymphoma
Published 5 years ago • 94 plays • Length 0:56Download video MP4
Download video MP3
Similar videos
-
4:05
selecting therapy for relapsed-refractory dlbcl
-
2:25
two doses of polatuzumab vedotin in patients with relapsed/refractory follicular lymphoma
-
3:41
treatment options for relapsed follicular lymphoma
-
4:53
follicular lymphoma: selecting therapy at relapse
-
19:05
update: relapsed/refractory follicular lymphoma
-
2:57
challenges in the treatment of follicular lymphoma
-
3:25
staging relapsed follicular lymphoma
-
2:00
clinical trial tests nivolumab for patients with rare brain and spine cancers
-
4:37
prognosis and treatment of follicular lymphoma
-
4:34
treating relapsed/refractory follicular lymphoma
-
2:15
identifying and treating follicular lymphoma patients with disease progression
-
22:46
follicular lymphoma debate: does chemotherapy have a major role to play?
-
4:30
follicular lymphoma relapsed/refractory disease
-
6:50
treatment after progression in follicular lymphoma
-
1:38
elara: tisagenlecleucel in patients with relapsed/refractory follicular lymphoma
-
35:12
relapsed and refractory follicular lymphoma
-
6:15
therapy for relapsed follicular lymphoma
-
2:10
challenges in treating patients with hl who relapse after autosct & novel therapies being explored
-
2:31
novel therapies for patients with follicular lymphoma